A study of nuclear transcription factor-kappa B in childhood autism

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Naik, Usha S ^a   Gangadharan, Charitha ^b   Abbagani, Kanakalatha ^a   Nagalla, Balakrishna ^c   Dasari, Niranjan ^a   Manna, Sunil K ^b  

^a OSMANIA MEDICAL COLLEGE   (India)

^b CENTRE FOR DNA FINGERPRINTING AND DIAGNOSTICS   (India)

^c NATIONAL INSTITUTE OF NUTRITION   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ARTICLE; BINDING AFFINITY; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DNA BINDING; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE ACTIVATION; GENE FUNCTION; GENE SWITCHING; HUMAN; INFANTILE AUTISM; MALE; PRESCHOOL CHILD; SCHOOL CHILD; SIGNAL TRANSDUCTION; ADULT; AUTISM; CELL CULTURE; METABOLISM;

BACTERIA (MICROORGANISMS);

ADULT; AUTISTIC DISORDER; CELLS, CULTURED; CHILD, PRESCHOOL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; HUMANS; MALE; NF-KAPPA B;

EID: 79955836984     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019488     Document Type: Article

References (34)

1. Volkmar FR, (2009) Pervasive Developmental Disorders. In: Sadock BJ, Sadock VA, Ruiz Lipincott P, editors. Comprehensive Textbook of Psychiatry Vol II, 9th Ed New York Williams and Wilkins pp. 3540-3551.
2. Kanner L, (1943) Autistic disturbances of affective contact. Nerv Child 2: 217-250.
3. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. Text Revision (DSM-IV-TR®) Washington, DC American Psychiatry Press.
4. Lord C, Shulman C, DiLavore P, (2004) Regression and word loss in autistic spectrum disorders. J Child Psychol Psychiatry 45: 936-955.
5. Licinio J, Alvarado I, Wong ML, (2002) Auto immunity in Autism. Editorial. Mol Psychiatry 4: 329.
6. Jyonouchi H, Sun S, Le H, (2001) Proinflammatory and regulatory cytokine production associated with innate and adaptive immune response in children with autism spectrum disorders and developmental regression. J Neuroimmunol 120: 170-179.
7. Zimmerman AW, Jyonouchi H, Corni AM, Connors SL, Mistien S, et al. (2005) Cerebrospinal fluid and serum markers of inflammation in autism. Pediatric Neurol 33: 195-201.
8. Goines P, Van de Water J, (2010) The immune system's role in the biology of autism. Curr Opin Neurol 23: 111-117.
9. Baltimore D, (2006) Handbook of Transcription Factor NF-kB. In: Ghosh S, editors. Boca Raton CRC Press.
10. Manna SK, Babajan B, Raghavendra PB, Raviprakash N, Sureshkumar C, (2010) Inhibiting TRAF 2 -mediated activation of NF-kB facilitates induction of AP-1. J Biol Chem 285: 11617-11627.
11. Ahn KS, Aggarwal BB, (2005) Transcription Factor NF-kB A sensor for smoke and stress signals. Ann N Y Acad Sci 1056: 218-233.
12. Phal LH, (1999) Activators and target genes of Rel/NF-kB transcription factors. Oncogene 18: 6853-6866.
13. Aggarwal BB, (2004) Nuclear factor-kB: the enemy within. Cancer Cell 6: 203-208.
14. Shimokawa I, (2004) Oxidative stress and calorie restriction. Geriatrics Gerontol Int 4: S149-S151.
15. Manna SK, Zhang HJ, Yan Y, Oberley LW, Aggarwal BB, (1998) Overexpression of Mn-Superoxide Dismutase suppresses TNF-induced apoptosis and activation of Nuclear Transcription Factor-kB and Activated Protein-1. J Biol Chem 273: 13245-13254.
16. Manna SK, Kuo MT, Aggarwal BB, (1999) Overexpression of gamma-glutamylcysteine synthetase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappa B and activator protein-1. Oncogene 18: 4371-4382.
17. Sajdel-Sulkowska ME, Windom H, Audhya T, McGinnis W, (2008) Oxidative stress in autism: Elevated cerebellar 3-nitrotyrosine levels. Am J Biochem and Biotechnol 4: 73-84.
18. Chez MG, Dowling T, Patel PB, Khanna P, Kominsky M, (2007) Elevation of Tumor Necrosis Factor Alpha in CSF of autistic children. Ped Neurol 36: 361-365.
19. Gillberg C, Gillberg IC, (1983) Infantile Autism; A total population study of reduced optimality in the pre-, peri-, and neonatal periods. J Autism and Dev Dis 13: 153-166.
20. Bale TL, Baram TZ, Brown TS, Goldstein JM, Insel TR, et al. (2010) Eary life programming and neurodevelopmental disorders. Biol Psychiatry 68: 314-319.
21. Schopler E, Reichler RJ, Renner BR, (1988) The Childhood Autism Rating Scale. Western Psychological Services.
22. Kelley E, Naigles L, Fein D, (2010) An in-depth examination of optimal outcome children with a history of autism spectrum disorders. Research in Autism Spectrum Disorders 4: 526-538.
23. Granpeesheh D, Tarbox J, Dixon DR, Carr E, Herbert M, (2009) Retrospective analysis of clinical records in 38 cases of recovery from autism. Ann Clin Psychiatry 4: 195-204.
24. Ashwood P, Krakowiak P, Hertz-Piccoitto I, Hansen R, Pessah I, et al. (2011) Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun 25: 40-45.
25. Shen C, Zhao XL, Ju W, Zou XB, Huo LR, et al. (2011) A proteomic investigation of B lymphocytes in an autistic family: A pilot study of exposure to natural latex (NRL) may lead to autism. J Mol Neuroscience 43: 443-452.
26. Vargas LD, Nascimbene C, Krishnan C, Zimmerman WA, Pardo AC, (2005) Neuroglial Activation and Neuroinflammation in the brain of patients with autism. Ann Neurol 57: 67-81.
27. Pardo AC, Vargas LD, Zimmerman WA, (2005) Immunity, neuralgia and neuroinflammation in autism. Intl Rev Psychiatry 17: 485-495.
28. Grosjean-Raillard J, Ades L, Boehrer S, Tailler M, Fabre C, et al. (2008) Flt3 receptor inhibition reduces constitutive NF kB activation in high risk myelodysplastic syndrome and acute myeloid leukemia. Apoptosis 13: 1148-1161.
29. Ghosh S, (2006) The NF Kappa pathway: A paradigm for inducible gene expression. In: Ghosh S, editors. Handbook of Transcription Factor NF-kB Boca Raton CRC Press pp. 1-7.
30. James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, et al. (2004) Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutri 80: 1611-1617.
31. Ghosh S, Hayden MS, (2008) New regulators of NF-kB in Inflammation. Nature Reviews Immnol 8: 837-848.
32. Vallabhapurapu S, Karin M, (2009) Regulation and function of NF-KB transcription in the immune system. Annu Rev Immunol 27: 693-733.
33. Malik M, Sheikh AM, Wen G, Spivack W, Brown WT, et al. (2011) Expression of inflammatory cytokines, Bcl2 and cathepsin D are altered in lymphoblasts of autistic subjects. Immunobiol 216: 80-85.
34. Thoh M, Kumar P, Nagarajaram HA, Manna SK, (2010) Azadirachtin interacts with the Tumor Necrosis Factor (TNF) binding domain of its receptors and inhibits TNF-induced Biological Responses. J Biol Chem 285: 5888-5895.